Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers (Q40425901)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q40073451)
(P304) 3385-3391
(P407) (Q1860)
(P433) 9
(P478) 11
(P577) Sunday, May 1, 2005
(P921) (Q323936)
(Q725307)
(P1433) (Q332253)
(P1476) "Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers." (language: en)
(P2093) Ramesh K Ramanathan
Donald L Trump
Julie L Eiseman
Sanjiv S Agarwala
Eleanor G Zuhowski
Jing Lan
Douglas M Potter
S Percy Ivy
Sakkaraiappan Ramalingam
Adam M Brufsky
Michael K K Wong
Susan Tutchko
Merrill J Egorin
other details
description scientific article

External Links